| Patent | Date |
|---|
Human CDR-grafted antibody and antibody fragment thereof
Grant 10,590,203 - Shitara , et al. | 2020-03-17 |
Human CDR-grafted antibody and antibody fragment thereof
Grant 10,131,711 - Shitara , et al. November 20, 2 | 2018-11-20 |
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20180030146 - SHITARA; Kenya ; et al. | 2018-02-01 |
Medicament comprising recombinant antibody against chemokine receptor CCR4
Grant 9,675,625 - Shitara , et al. June 13, 2 | 2017-06-13 |
Recombinant antibody composition
Grant 9,475,886 - Shitara , et al. October 25, 2 | 2016-10-25 |
Recombinant Antibody Composition
App 20160108136 - SHITARA; Kenya ; et al. | 2016-04-21 |
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20150315285 - SHITARA; Kenya ; et al. | 2015-11-05 |
Human CDR-grafted antibody and antibody fragment thereof
Grant 9,051,371 - Shitara , et al. June 9, 2 | 2015-06-09 |
Human CDR-grafted antibody and antibody fragment thereof
Grant 8,900,584 - Shitara , et al. December 2, 2 | 2014-12-02 |
Recombinant antibody composition
Grant 8,883,981 - Shitara , et al. November 11, 2 | 2014-11-11 |
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20140186349 - Shitara; Kenya ; et al. | 2014-07-03 |
Method for producing recombinant antibody and antibody fragment thereof
Grant 8,632,996 - Shitara , et al. January 21, 2 | 2014-01-21 |
Monoclonal Antibody Capable Of Binding To Heparin-binding Epidermal Growth Factor-like Growth Factor
App 20130337505 - MEKADA; Eisuke ; et al. | 2013-12-19 |
Medicament Comprising Recombinant Antibody Against Chemokine Receptor Ccr4
App 20130295045 - SHITARA; Kenya ; et al. | 2013-11-07 |
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20130273038 - SHITARA; Kenya ; et al. | 2013-10-17 |
Medicament comprising recombinant antibody against chemokine receptor CCR4
Grant 8,491,902 - Shitara , et al. July 23, 2 | 2013-07-23 |
Effector function enhanced recombinant antibody composition
Grant 8,492,526 - Shitara , et al. July 23, 2 | 2013-07-23 |
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
Grant 8,481,039 - Mekada , et al. July 9, 2 | 2013-07-09 |
Method of enhancing of binding activity of antibody composition to Fc.gamma. receptor IIIa
Grant 8,313,913 - Nakamura , et al. November 20, 2 | 2012-11-20 |
Gene Recombinant Antibody And Antibody Fragment Thereof
App 20120276090 - SHITARA; Kenya ; et al. | 2012-11-01 |
Monoclonal Antibody Capable Of Binding To Heparin-binding Epidermal Growth Factor-like Growth Factor
App 20120177649 - MEKADA; Eisuke ; et al. | 2012-07-12 |
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20120177643 - Shitara; Kenya ; et al. | 2012-07-12 |
Method for treating the Th2-mediated disease
Grant 8,197,814 - Shitara , et al. June 12, 2 | 2012-06-12 |
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
Grant 8,173,781 - Mekada , et al. May 8, 2 | 2012-05-08 |
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
Grant 8,163,282 - Mekada , et al. April 24, 2 | 2012-04-24 |
Human CDR-grafted antibody and antibody fragment thereof
Grant 8,143,058 - Shitara , et al. March 27, 2 | 2012-03-27 |
Method Of Depleting Regulatory T Cell
App 20120020962 - UEDA; Ryuzo ; et al. | 2012-01-26 |
Effector Function Enhanced Recombinant Antibody Composition
App 20120022238 - SHITARA; Kenya ; et al. | 2012-01-26 |
Anti-perp antibody
Grant 8,093,361 - Ochiai , et al. January 10, 2 | 2012-01-10 |
Genetically Recombinant Antibody Composition Capable Of Binding Specifically To Ganglioside Gm2
App 20110236374 - Shitara; Kenya ; et al. | 2011-09-29 |
Effector function enhanced recombinant antibody composition
Grant 7,994,290 - Shitara , et al. August 9, 2 | 2011-08-09 |
Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof
Grant 7,939,077 - Shitara , et al. May 10, 2 | 2011-05-10 |
Recombinant antibody composition
Grant 7,923,538 - Shitara , et al. April 12, 2 | 2011-04-12 |
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20110059524 - SHITARA; Kenya ; et al. | 2011-03-10 |
Monoclonal Antibody Capable Of Binding To Heparin-binding Epidermal Growth Factor-like Growth Factor
App 20110052595 - MEKADA; Eisuke ; et al. | 2011-03-03 |
Monoclonal Antibody Capable Of Binding To Heparin-binding Epidermal Growth Factor-like Growth Factor
App 20110034673 - MEKADA; Eisuke ; et al. | 2011-02-10 |
Recombinant Antibody Composition
App 20110009600 - SHITARA; Kenya ; et al. | 2011-01-13 |
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
Grant 7,851,601 - Mekada , et al. December 14, 2 | 2010-12-14 |
Human CDR-grafted antibody and antibody fragment thereof
Grant 7,842,797 - Shitara , et al. November 30, 2 | 2010-11-30 |
Method for Treating the TH2-Mediated Disease
App 20100221178 - SHITARA; Kenya ; et al. | 2010-09-02 |
Monoclonal Antibody Capable Of Binding To Heparin-binding Epidermal Growth Factor-like Growth Factor
App 20100184958 - MEKADA; EISUKE ; et al. | 2010-07-22 |
Method of Depleting Regulatory T Cell
App 20100150917 - UEDA; Ryuzo ; et al. | 2010-06-17 |
Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa
App 20100092997 - Nakamura; Kazuyasu ; et al. | 2010-04-15 |
Antibody composition-containing medicament
Grant 7,691,568 - Niwa , et al. April 6, 2 | 2010-04-06 |
Method for treating Th2-mediated disease
Grant 7,666,418 - Shitara , et al. February 23, 2 | 2010-02-23 |
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 7,615,215 - Shitara , et al. November 10, 2 | 2009-11-10 |
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 7,615,214 - Shitara , et al. November 10, 2 | 2009-11-10 |
Anti-Perp Antibody
App 20090258007 - Ochiai; Atsushi ; et al. | 2009-10-15 |
Medicaments Comprising Gene Recombinant Antibody Against Ganglioside Gd3
App 20090226399 - Shitara; Kenya ; et al. | 2009-09-10 |
Human CDR-Grafted Antibody and Antibody Fragment Thereof
App 20090227012 - SHITARA; Kenya ; et al. | 2009-09-10 |
Human CDR-grafted antibody and antibody fragment thereof
Grant 7,504,104 - Shitara , et al. March 17, 2 | 2009-03-17 |
Recombinant antibody against human insulin-like growth factor
Grant 7,498,415 - Shitara , et al. March 3, 2 | 2009-03-03 |
Antibody Composition Specifically Binding to Ganglioside Gm
App 20090028877 - Iida; Shigeru ; et al. | 2009-01-29 |
Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor
Grant 7,479,371 - Ando , et al. January 20, 2 | 2009-01-20 |
Effector Function Enhanced Recombinant Antibody Composition
App 20090004186 - SHITARA; Kenya ; et al. | 2009-01-01 |
Antibody against human insulin-like growth factor
Grant 7,438,911 - Shitara , et al. October 21, 2 | 2008-10-21 |
Fused Protein Composition
App 20080241884 - Shitara; Kenya ; et al. | 2008-10-02 |
Method for Treating CCR4-Related Diseases
App 20080213266 - Iida; Shigeru ; et al. | 2008-09-04 |
Anti-human Vegf Receptor Flt-1 Monoclonal Antibody
App 20080187529 - Shitara; Kenya ; et al. | 2008-08-07 |
Methods using eosinophil-specific apoptosis inducer
Grant 7,404,953 - Hosaka , et al. July 29, 2 | 2008-07-29 |
Medicaments Comprising Gene Recombinant Antibody Against Ganglioside Gd3
App 20080166345 - SHITARA; Kenya ; et al. | 2008-07-10 |
IL-5R-specific antibody composition
App 20080095765 - Ilda; Shigeru ; et al. | 2008-04-24 |
Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3
Grant 7,253,263 - Hanai , et al. August 7, 2 | 2007-08-07 |
Anti-fibroblast growth factor-8 monoclonal antibody
Grant 7,241,568 - Hanai , et al. July 10, 2 | 2007-07-10 |
Recombinant antibody composition
App 20070148165 - Shitara; Kenya ; et al. | 2007-06-28 |
Process for producing humanized chimera antibody
App 20070073043 - Shitara; Kenya ; et al. | 2007-03-29 |
Medicine containing genetically modified antibody against chemokine receptor ccr4
App 20070020263 - Shitara; Kenya ; et al. | 2007-01-25 |
Cancer metastasis inhibitor
App 20060263362 - Ochiai; Atsushi ; et al. | 2006-11-23 |
Recombinant antibody against human insulin-like growth factor
App 20060240015 - Shitara; Kenya ; et al. | 2006-10-26 |
Antibody against human insulin-like growth factor
App 20060165695 - Shitara; Kenya ; et al. | 2006-07-27 |
Process for purifying antibody
Grant 7,064,191 - Shinkawa , et al. June 20, 2 | 2006-06-20 |
Anti-human VEGF receptor FLT-1 monoclonal antibody
Grant 7,052,693 - Shitara , et al. May 30, 2 | 2006-05-30 |
Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3
Grant 7,045,129 - Shitara , et al. May 16, 2 | 2006-05-16 |
Process for producing humanized chimera antibody
App 20060058512 - Shitara; Kenya ; et al. | 2006-03-16 |
Process for producing humanized chimera antibody
App 20060057139 - Shitara; Kenya ; et al. | 2006-03-16 |
Anti-human VEGF receptor Flt-1 monoclonal antibody
App 20060034838 - Shitara; Kenya ; et al. | 2006-02-16 |
Method of depleting regulatory T cell
App 20060034841 - Ueda; Ryuzo ; et al. | 2006-02-16 |
Recombinant antibody and antibody fragment
Grant 6,989,145 - Shitara , et al. January 24, 2 | 2006-01-24 |
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 6,986,890 - Shitara , et al. January 17, 2 | 2006-01-17 |
CCR4-specific antibody composition
App 20050287138 - Iida, Shigeru ; et al. | 2005-12-29 |
Drugs containing genetically modified antibody against ganglioside gd3
App 20050260206 - Shitara, Kenya ; et al. | 2005-11-24 |
Process for producing humanized chimera antibody
Grant 6,965,024 - Shitara , et al. November 15, 2 | 2005-11-15 |
IL-5R-specific antibody composition
App 20050226867 - Iida, Shigeru ; et al. | 2005-10-13 |
Method for treating Th2-mediated disease
App 20050187380 - Shitara, Kenya ; et al. | 2005-08-25 |
Humanized antibodies
Grant 6,872,392 - Nakamura , et al. March 29, 2 | 2005-03-29 |
Therapeutic agent for patients having human FcgammaRIIIa
App 20050031613 - Nakamura, Kazuyasu ; et al. | 2005-02-10 |
Substance which inhibits binding of information transfer molecule for 1175-tyrosine phosphorylated KDR/Flk-1 and usages of the same
App 20050004003 - Shibuya, Masabumi ; et al. | 2005-01-06 |
Method of enhancing of binding activity of antibody composition to Fcgamma receptor IIIa
App 20040259150 - Nakamura, Kazuyasu ; et al. | 2004-12-23 |
Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof
App 20040253234 - Shitara, Kenya ; et al. | 2004-12-16 |
Monoclonal antibody binding to mt4-mmp catalytic domain
App 20040175825 - Miki, Ichiro ; et al. | 2004-09-09 |
Eosinophil-specific apoptosis inducer
App 20040136996 - Hosaka, Emi ; et al. | 2004-07-15 |
Antibody composition-containing medicament
App 20040109865 - Niwa, Rinpei ; et al. | 2004-06-10 |
Anti-fibroblast growth factor-8 monoclonal antibody
App 20040091480 - Hanai, Nobuo ; et al. | 2004-05-13 |
Antibody composition which specifically binds to CD20
App 20040093621 - Shitara, Kenya ; et al. | 2004-05-13 |
Antibody inhibiting vplf activity
App 20040086507 - Shitara, Kenya ; et al. | 2004-05-06 |
VEGF activity inhibitor
App 20030175271 - Shitara, Kenya ; et al. | 2003-09-18 |
Human CDR-grafted antibody and antibody fragment thereof
App 20030175273 - Shitara, Kenya ; et al. | 2003-09-18 |
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 6,617,160 - Shitara , et al. September 9, 2 | 2003-09-09 |
Process for producing humanized chimera antibody
App 20030095964 - Shitara, Kenya ; et al. | 2003-05-22 |
Anti-human VEGF receptor Flt-1 monoclonal antibody
App 20030088075 - Shitara, Kenya ; et al. | 2003-05-08 |
Humanized antibodies
App 20030077276 - Nakamura, Kazuyasu ; et al. | 2003-04-24 |
Substance which inhibits binding of information transfer molecule for 1175-tyrosine phosphorylated KDR/FLK-1 and usages of the same
App 20030022247 - Shibuya, Masabumi ; et al. | 2003-01-30 |
Process for purifying antibody
App 20020164328 - Shinkawa, Toyohide ; et al. | 2002-11-07 |
Human chimeric antibody specific for the ganglioside GD3
Grant 6,437,098 - Shitara , et al. August 20, 2 | 2002-08-20 |
Gene recombinant antibody and antibody fragment thereof
App 20020098527 - Shitara, Kenya ; et al. | 2002-07-25 |
Process for producing humanized chimera antibody
App 20020026036 - Shitara, Kenya ; et al. | 2002-02-28 |
Humanized antibodies to ganglioside GM.sub.2
Grant 5,939,532 - Nakamura , et al. August 17, 1 | 1999-08-17 |
DNA encoding humanized antibodies specific for the ganglioside GM.sub.2
Grant 5,874,255 - Nakamura , et al. February 23, 1 | 1999-02-23 |
Process for producing humanized chimera antibody
Grant 5,866,692 - Shitara , et al. February 2, 1 | 1999-02-02 |
Method of treating cancer using a chimera antibody
Grant 5,807,548 - Shitara , et al. September 15, 1 | 1998-09-15 |
Process for producing humanized chimera antibody
Grant 5,750,078 - Shitara , et al. May 12, 1 | 1998-05-12 |
| 